The biological medicines or biopharmaceuticals, sometimes also called as the 
development of pharmaceuticals has revolutionized the approach of diseases 
treatment.CAR-T cell treatments for specific 
tumours and gene therapies for genetic disorders like spinal muscular atrophy are the 
well-known example (Arabi et al., 2022).In comparison to the conventional small-molecule medications, these
innovative and novel treatments are developed from living things or their byproducts, 
such as nucleic acids, proteins, or cells, and they provide extremely well focused and 
specialized methods of treatments (Moorkens et al., 2016).Therapeutic proteins like insulin and human growth hormone can now be produced 
using Genetically engineered microorganisms or cell lines are utilized to produce the 
therapeutic protein like human growth regulator and insulin due to this groundbreaking 
discovery (Kumar, 2020).Stanley Cohen and Herbert Boyer laid the foundation for recombinant DNA technology 
in the 1970s and credited to start the biomedicine industry (Ferrer-Miralles et al., 2009).